Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

Jennifer A. Chan

Susan Geyer

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

Tyler Zemla

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

Michael V. Knopp

Wright Center of Innovation and the Imaging and Radiation Oncology Core, University of Cincinnati, Cincinnati

Spencer Behr

University of California, San Francisco, San Francisco

Sydney Pulsipher

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

Fang-Shu Ou

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

Amylou C. Dueck

Alliance Statistics and Data Management Center, Mayo Clinic, Scottsdale, AZ

Jared Acoba

University of Hawaii Cancer Center, Honolulu

Ardaman Shergill

Alliance for Clinical Trials in Oncology, Chicago

Edward M. Wolin

Mount Sinai Medical Center, New York

Thorvardur R. Halfdanarson

Mayo Clinic Comprehensive Cancer Center, Rochester, MN

Bhavana Konda

Ohio State University Comprehensive Cancer Center, Columbus

Nikolaos A. Trikalinos

Washington University School of Medicine, St. Louis

Bernard Tawfik

University of New Mexico Comprehensive Cancer Center, Albuquerque

Nitya Raj

Memorial Sloan Kettering Cancer Center, New York

Shagufta Shaheen

Stanford Cancer Center, Stanford, CA

Namrata Vijayvergia

Fox Chase Cancer Center, Philadelphia

Arvind Dasari

M.D. Anderson Cancer Center, Houston

Jonathan R. Strosberg

Moffitt Cancer Center, Tampa, FL

Elise C. Kohn

National Cancer Institute, Bethesda, MD

Matthew H. Kulke

Boston Medical Center, Boston

Eileen M. O’Reilly

Jeffrey A. Meyerhardt